Business development: Secures royalty economic interests in two early stage partnered assets through XOMA Royalty’s announced expected acquisition of LAVA Therapeutics. Company acquisitions: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback